Hutchin Hill Capital’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $668K | Buy |
12,400
+2,100
| +20% | +$113K | 0.19% | 125 |
|
|
2017
Q3 | $597K | Sell |
10,300
-11,500
| -53% | -$667K | 0.02% | 479 |
|
|
2017
Q2 | $1.08M | Buy |
+21,800
| New | +$1.08M | 0.04% | 477 |
|
|
2015
Q4 | – | Sell |
-30,300
| Closed | -$964K | – | 605 |
|
|
2015
Q3 | $964K | Buy |
+30,300
| New | +$964K | 0.04% | 405 |
|
|
2015
Q2 | – | Sell |
-34,900
| Closed | -$1.44M | – | 623 |
|
|
2015
Q1 | $1.44M | Buy |
+34,900
| New | +$1.44M | 0.04% | 357 |
|
|
2014
Q4 | – | Sell |
-46,400
| Closed | -$1.7M | – | 533 |
|
|
2014
Q3 | $1.7M | Buy |
46,400
+14,800
| +47% | +$543K | 0.06% | 264 |
|
|
2014
Q2 | $1.46M | Sell |
31,600
-9,000
| -22% | -$417K | 0.07% | 245 |
|
|
2014
Q1 | $1.67M | Sell |
40,600
-1,700
| -4% | -$69.9K | 0.09% | 250 |
|
|
2013
Q4 | $1.61M | Buy |
+42,300
| New | +$1.61M | 0.11% | 189 |
|
|
2013
Q3 | – | Sell |
-12,400
| Closed | -$211K | – | 475 |
|
|
2013
Q2 | $211K | Buy |
+12,400
| New | +$211K | 0.02% | 374 |
|